ESLAEstrella Immunopharma Inc. Common Stock
0.7353USD-0.20%Mkt Cap: 31.98M $P/E: —3d ago
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in Phase…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap31.98M $
Enterprise Value32.26M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-13.06M $
Revenue/Share—
Last Price0.7353 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.33
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-4.31
EPS (TTM)-0.25
EPS (Forward)-0.32
52W Range
0.67812% of range3.150
52W High3.150 USD
52W Low0.6781 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE126.02%
ROA-411.19%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.79M $
CapEx (TTM)—
FCF Margin—
FCF Yield-21.14%
Net Debt-146.67K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.20
Quick Ratio0.02
Book Value/Sh-0.1730 USD
Cash/Share0.0030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)12.00 USD
Upside (mean)+1532.0%
Target Range12.00 USD – 12.00 USD
# Analysts1
Ownership
Shares Out.43.50M
Float14.26M
Insiders59.96%
Institutions11.14%
Short Interest
Short Ratio1.0d
Short % Float0.28%
Short % Out.0.11%
Shares Short48.05K
Short (prev mo.)89.08K
Technical
SMA 500.8540 (-13.9%)
SMA 2001.296 (-43.2%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)37.91K
Avg Vol (10d)28.78K
Technical Indicators
RSI (14)42.7
MACD-0.0374
MACD Signal-0.0497
MACD Hist.+0.0122
BB Upper0.7871 USD
BB Middle0.7374 USD
BB Lower0.6877 USD
BB Width13.48%
ATR (14)0.0649 USD
Vol Ratio (20d)0.29x